Insights on Pharmaceuticals & Medical Products

Article

The rise and rise of medtech in Asia
– How can medtech companies thrive in the world’s fastest-growing market?
Article

Developing tomorrow’s leaders in life sciences
– In a sector undergoing unprecedented change, five muscles will define the successful leaders of the future.
Article

What’s behind the pharmaceutical sector’s M&A push
– There are lessons for other industries in the way pharma companies use mergers to innovate, work more efficiently, and bolster... product portfolios.
Article

R&D in the ‘age of agile’
– As innovation reshapes the pharma landscape, pharma companies will need to revisit their R&D operating models to thrive.
Article

Change in the Japanese pharmaceutical market: Cradle of innovation or grave of corporate profits?
– Understanding structural shifts in the market can help pharma stakeholders innovate and, ultimately, deliver benefits for patients.

Special Collections

Biopharma Frontiers:
What the future holds for the industry
Industry leaders and key stakeholders offer perspectives to inspire discussion and constructive debate.

The pharma launchpad
Ideas for pharma and biotech looking to invest for launch success.

Spotlight on Japan
As the world’s second-largest pharma and medtech market, Japan has historically been an innovation center for the industry.... But amid an evolving healthcare landscape, this collection of articles and interviews looks at what opportunities and challenges executives at life-sciences companies need to address.

Want to learn more about how we help clients in Pharmaceuticals & Medical Products?

Learn more

More insights

Interview

Building digital ecosystems in Japan
– Two Merck Healthcare digital specialists explain their company’s transformation and the impact it has had on patients.
Collection

Digital R&D: The Next Frontier for Biopharmaceuticals
– Digital promises to transform R&D productivity over the next decade. What will it take to realize this potential?
Article

Digitizing healthcare—opportunities for Germany
– Society is aging and healthcare costs keep rising. By digitizing the system, health services can be provided at lower cost and... higher quality. A new study reveals the areas for and extent of potential improvements.
Article

Genetic testing: Opportunities to unlock value in precision medicine
– Advanced analysis of genomic data integrated with electronic medical records and other data sets, combined with effective reimbursement... strategies and full data-regulatory compliance, will distinguish winning diagnostics companies.
Article

Barriers to Digital@Scale: Shifting the focus from tech to culture
– Many pharma and medtech companies have a digital strategy. But to pull off a true digital transformation, it's crucial to focus... on culture and mindset, according to leaders who attended a recent European roundtable.
Report

Data driven decisions in cancer care
– EMR- and biomarker-based diagnostics are now ubiquitous in oncology. But several factors hinder greater use of automation and... analytics-driven decisions. This paper examines these limitations and suggests solutions.
Article

From product to customer experience: The new way to launch in pharma
– In increasingly crowded drug markets, a strong clinical profile is no longer enough to ensure a distinctive launch. To be successful,... pharma companies need to launch not only products but also experiences.
Article - McKinsey Quarterly

Shaking up the value chain
– Data and digitization are creating a growing array of value-creation choices in industries as diverse as pharmaceuticals, mining,... and energy.
Interview

Leading change in the Japanese pharma market: Innovating for the future in an uncertain present
– Jacques Nathan, president of Sanofi Japan, discusses what’s ahead for his changing sector.
Article

How data is changing the pharma operations world
– Pharma companies have a great opportunity to turn a buzzword into exponential impact.
Interview

Bringing an animal health business into the fold
– Two senior Boehringer Ingelheim executives, Joachim Hasenmaier and Felix Gutsche, discuss the global pharmaceutical company’s... deal with Sanofi to acquire its animal health business.
Sorry, we couldn't find any results. Try removing some filters.
View more

Related practices

Connect with our Pharmaceuticals & Medical Products Practice

Contact